In our data, these genes were down-regulated due to rapamycin treatment opposite to the observation in clinical breast tumors, in which these genes were up-regulated together with AKT1. These results support the idea that these genes are co-expressed with AKT1, although based on our data their role in rapamycin sensitivity could not be confirmed. Here, AKT1 is linked to breast neoplasm.